Just a decade after it initially hit the market, Botox is one of the most popular cosmetic medical procedure in the United States. Celebrities and the wealthy have poured a lot of money into the procedure to look young and now activist investor Carl Icahn is betting on it. Icahn just announced that he has … Continue reading “Carl Icahn Gives In To Botox By Buying Stake In Allergan (NYSE: ACT)”
Author: Sophia Vida
The World’s Most Luxurious Submersible Yacht Is Here
Just when you thought you couldn't get any more fancier than sipping wine on a…
Apple’s (NASDAQ: AAPL) iPhone Rumored To Move To 3-Year Cycle
We finally may be able to actually enjoy our phones for awhile before temptations for…
James Bond Director Sam Mendes Quits, Is Daniel Craig Next?
Though he only directed the last two Bond flicks, Skyfall and Spectre, director Sam Mendes…
Glu Mobile (NASDAQ: GLUU) Gets A Piece of Britney Spears
Kim Kardashian has made millions with her app, now it's Britney Spears' turn to cash…
T-Mobile (NASDAQ: TMUS) To Acquire AT&T’s (NYSE: T) Spectrum
People in Chicago may soon have something to smile about when it comes to their…
This 21 Year Old Turned $1,500 Into $1 Million
While many college students are working two jobs to pay their tuition, Jason Pelts from…
Justin Bieber and Skrillex Are Not Sorry
A lawsuit filed by artist Casey Dienel was filed last week claiming that Justin Bieber…
30 Maseratis Pulled Over By NY Police
In what may have looked like a scene from Fast and the Furious (the ultra…
This Company’s Employees Are Choosing Suicide
Is there something in the water or is the pressure at big companies too much…
Massive Verizon (NYSE: VZ) Labor Strike Finally Comes To An End
Nearly 40,000 Verizon landline employees will be returning to work after being on strike for…
Gorilla Killing At Cincinnati Zoo Sparks Outrage
This is one of those stories that makes any animal lover's skin boil. A defenseless…
Orexigen Therapeutics, Inc. (NASDAQ: OREX) Co-Founder Has Left The Building
Orexigen Therapeutics is a biopharmaceutical company that looks to be trading rather out of the…
Aeterna Zentaris Inc. (NASDAQ: AEZS) Is Trading Far From Last Year’s Highs
Just a year ago, shares of Aeterne Zentaris were trading at $52.50. Today the stock…
